Epidermal growth factor receptor targeting in cancer: a review of trends and strategies

C Yewale, D Baradia, I Vhora, S Patil, A Misra - Biomaterials, 2013 - Elsevier
The epidermal growth factor receptor (EGFR) is a cell-surface receptor belonging to ErbB
family of tyrosine kinase and it plays a vital role in the regulation of cell proliferation, survival …

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

J Mendelsohn, J Baselga - Journal of clinical oncology, 2003 - ascopubs.org
The epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor of the ErbB family
that is abnormally activated in many epithelial tumors. Receptor activation leads to …

STAT proteins: novel molecular targets for cancer drug discovery

J Turkson, R Jove - Oncogene, 2000 - nature.com
Abstract Signal Transducers and Activators of Transcription (STATs) are a family of
cytoplasmic proteins with roles as signal messengers and transcription factors that …

Immunotoxins for targeted cancer therapy

RJ Kreitman - The AAPS journal, 2006 - Springer
Immunotoxins are proteins that contain a toxin along with an antibody or growth factor that
binds specifically to target cells. Nearly all protein toxins work by enzymatically inhibiting …

The complexity of targeting EGFR signalling in cancer: from expression to turnover

S Sebastian, J Settleman, SJ Reshkin, A Azzariti… - … et Biophysica Acta (BBA …, 2006 - Elsevier
The epidermal growth factor receptor (ErbB1 or EGFR) has been found to be altered in a
variety of human cancers. A number of agents targeting these receptors, including specific …

Epidermal growth factor receptor: a promising target in solid tumours

JJ Laskin, AB Sandler - Cancer treatment reviews, 2004 - Elsevier
The epidermal growth factor receptor (EGFR) is expressed in a wide variety of solid tumours.
It has been demonstrated that the EGFR-associated signaling pathway plays an important …

Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation

A Gschwind, N Prenzel, A Ullrich - Cancer research, 2002 - AACR
Transactivation of the epidermal growth factor receptor (EGFR) represents the paradigm for
cross-talk between G protein-coupled receptors (GPCRs) and receptor tyrosine kinase …

Rational bases for the development of EGFR inhibitors for cancer treatment

R Bianco, T Gelardi, V Damiano, F Ciardiello… - The international journal …, 2007 - Elsevier
Growth factor receptors and their ligands not only regulate normal cell processes but have
been also identified as key regulators of human cancer formation. The epidermal growth …

HER2 as a therapeutic target in head and neck squamous cell carcinoma

NI Pollock, JR Grandis - Clinical Cancer Research, 2015 - AACR
The majority of patients with head and neck squamous cell carcinoma (HNSCC) present
with advanced-stage disease. The current standard of care is surgery followed by adjuvant …

A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor …

C Di Paolo, J Willuda, S Kubetzko, I Lauffer… - Clinical Cancer …, 2003 - AACR
Purpose: Epithelial cell adhesion molecule (Ep-CAM) is a tumor-associated antigen
overexpressed in many solid tumors but shows limited expression in normal epithelial …